§ PHARMACEUTICALS
USD · PharmaceuticalsXERS
XERIS BIOPHARMA HOLDINGS INC
USDSector · PharmaceuticalsBeta · 0.78
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
154 increased/new, 64 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/E | 84.7 | P/B | 97.76 |
| EPS (TTM) | 0.06 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| BlackRock, Inc. | 12.9M | 0.0% | +2% |
| DE Shaw | 7.8M | 0.0% | +3% |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.0M | n/a | n/a |
| State Street | 4.7M | 0.0% | +13% |
| Geode Capital Management | 4.3M | 0.0% | +0% |
| Qube Research & Technologies Ltd | 4.1M | 0.0% | +18% |
◇ AC INTELLIGENCE
Top institutional owners for XERS as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER89.9% · 0 holders
OTHER4.6% · 168 holders
PASSIVE / INDEX2.0% · 8 holders
DEALER / BANK1.4% · 21 holders
ACTIVIST0.7% · 1 holder
QUALITY / COMPOUNDER0.7% · 14 holders
TACTICAL / MACRO0.3% · 3 holders
SYSTEMATIC / QUANT0.2% · 9 holders
INCOME / DEFENSIVE0.2% · 14 holders
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for XERS in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention XERS yet.